An association with vulval cancer and urothelial carcinoma with squamous differentiation in patients with neurogenic bladder has also been noted.
2.
For patients with spinal cord lesions and neurogenic bladder dysfunction, intermittent catheterisation ( IC ) is a standard method for bladder emptying.
3.
In February 2008, Dr . Mohan S . Gundeti of the University of Chicago Comer Children's Hospital performed the first robotic pediatric neurogenic bladder reconstruction.
4.
The appendix is also used for the construction of an efferent urinary conduit, in an operation known as the Mitrofanoff procedure, in people with a neurogenic bladder.
5.
Recurrent infections may be caused by inefficient urination ( benign prostatic hypertrophy, neurogenic bladder ), prostatic stones or a structural abnormality that acts as a reservoir for infection.
6.
In post void residual, a catheter is inserted into the urinary tract immediately after urinating to measure fluid still in the bladder . 50 100 ml suggests neurogenic bladder dysfunction.
7.
Common causes include bladder dysfunction ( such as neurogenic bladder ) and urethral obstruction ( such as posterior urethral valves in male infants ) or compression ( such as from prostatic hypertrophy in older male adults ).
8.
The frequent urge to urinate can also be a sign of some type of urinary tract obstruction-- for example, Benign prostatic hyperplasia, prostatitis, neurogenic bladder, or other functional derangement of the urethral sphincter.
9.
The company also develops the Neo-Bladder Augment, a Phase II clinical trial product for the treatment of neurogenic bladder resulting from spina bifida in pediatric patients, as well as neurogenic bladder resulting from spinal cord injury in adult patients; the Neo-Bladder Replacement to serve as a functioning bladder, eliminating the need for an ostomy bag, for patients who have their bladders removed due to cancer; and the Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease.
10.
The company also develops the Neo-Bladder Augment, a Phase II clinical trial product for the treatment of neurogenic bladder resulting from spina bifida in pediatric patients, as well as neurogenic bladder resulting from spinal cord injury in adult patients; the Neo-Bladder Replacement to serve as a functioning bladder, eliminating the need for an ostomy bag, for patients who have their bladders removed due to cancer; and the Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease.
मोबाइल